Top Markets
#1 Purr Purr +65.26%
#2 Pons Pons +53.51%
#3 Smilek to the Bank Smilek to the Bank +50.56%
#4 Non-Playable Coin Non-Playable Coin +35.04%
#5 ApeX ApeX +28.59%
#6 Kinetiq Kinetiq +25.32%
#7 Morpho Morpho +24.45%
#8 StonkBroker StonkBroker +22.20%
#9 Cash Cat Cash Cat +21.71%
#10 Grass Grass +20.97%
Coin of the day
Purr Purr
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Kinnate Biopharma Inc. Kinnate Biopharma Inc.

Kinnate Biopharma Inc.

KNTE
Rang in Aktien #21072
Kinnate Biopharma Inc. is a U.S.-based biopharmaceutical company primarily... Kinnate Biopharma Inc. is a U.S.-based biopharmaceutical company primarily focused on identifying and advancing small-molecule drugs that target kinase enzymes to treat cancers defined by specific genetic markers. The company's product pipeline includes: KIN-2787: An inhibitor of rapidly accelerated fibrosarcoma (RAF), currently being developed to treat patients with lung cancer, melanoma, and other forms of solid tumors. KIN-3248: A small-molecule kinase inhibitor designed to counteract cancer-associated genetic mutations in the fibroblast growth factor receptors, specifically FGFR2 and FGFR3. KIN004 Program: This program encompasses early-stage small-molecule research, including a Cyclin-Dependent Kinase 12 (CDK12) inhibitor. Established in 2018, Kinnate Biopharma Inc. maintains its headquarters in San Francisco, California. It was formerly a division of Fount Therapeutics, LLC.
Aktienkurs
$2.65
Zuletzt synchronisiert: 2024-04-03
Marktkapitalisierung
$115.71M
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
0.00%
Land
US
Handel Kinnate Biopharma Inc. (KNTE)

Kategorie

Healthcare
Preis KNTE mit Marktkapitalisierung von B
Kinnate Biopharma Inc. Kinnate Biopharma Inc.
KNTE
$2.65
Marktkapitalisierung von Kinnate Biopharma Inc.(KNTE)
Marktkapitalisierung: $115.71M
Mit Stand August 2026 hat Kinnate Biopharma Inc. eine Marktkapitalisierung von $115.71M. Das macht Kinnate Biopharma Inc. laut unseren Daten zum 21072nd wertvollsten Unternehmen der Welt nach Marktkapitalisierung. Die Marktkapitalisierung ist der Gesamtmarktwert aller ausstehenden Aktien eines börsennotierten Unternehmens und wird häufig verwendet, um den Unternehmenswert zu bestimmen.
Marktkapitalisierung von Kinnate Biopharma Inc. von 2020 bis 2026
KNTE im Vergleich zu den Top 5 der beliebtesten stocks
Preis für KNTE Vermögenswert B Marktkapitalisierung von B Ergebnisse
Kinnate Biopharma Inc. Kinnate Biopharma Inc.
$119,352 $115.71M
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.211T +4,503,754.68%
Kinnate Biopharma Inc. Kinnate Biopharma Inc.
$104,131 $115.71M
Apple Inc. Apple Inc.
AAPL
$4.547T +3,929,363.38%
Kinnate Biopharma Inc. Kinnate Biopharma Inc.
$95,330.13 $115.71M
Alphabet Inc. Alphabet Inc.
GOOG
$4.162T +3,597,263.24%
Kinnate Biopharma Inc. Kinnate Biopharma Inc.
$82,283.04 $115.71M
Microsoft Corporation Microsoft Corporation
MSFT
$3.593T +3,104,920.52%
Kinnate Biopharma Inc. Kinnate Biopharma Inc.
$63,962.69 $115.71M
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.793T +2,413,586.36%